Brad S. Lakhia, the Senior Vice President and Chief Financial Officer of CBIZ, Inc., has disposed of 141,019.95 shares of the company’s common stock. This transaction occurred on November 2, 2026, shortly after CBIZ's merger with Viking ParentCo, Inc. This event is significant as it highlights the ongoing structural changes within the company following the merger.
Background
CBIZ, Inc. is a provider of business services, operating under the SIC code for business services, NEC. The company is headquartered in Independence, Ohio, and trades on the stock market under the ticker symbol CBZ. Recent filings indicate that Lakhia has been active in reporting his stock transactions, with the latest filing being a Form 4 submitted on November 2, 2026, following a series of similar filings throughout 2026.
What the Filing Says
According to the SEC filing (accession number 0000944148-26-000125), Lakhia's transaction involved a direct disposal of shares. The filing noted, "Pursuant to the terms of the Agreement and Plan of Merger, dated as of July 28, 2026, each outstanding share of common stock... was canceled and converted into the right to receive $55.00 in cash per share." This indicates that the disposal of shares was part of the broader implications of the merger.
Impact
This transaction may affect various stakeholders, including CBIZ employees, shareholders, and investors. As CBIZ transitions post-merger, the market may react to changes in leadership and ownership structures. The merger itself is likely to influence the competitive dynamics within the business services sector, as competitors may need to reassess their strategies in light of CBIZ's new direction.
What's Next
The filing does not say what happens next.
Read Next
Smith Byron Jr. Acquires 1,160 Shares of Northern Trust Corp
Etsy CFO Charles Baker Reports Stock Transactions
Catalyst Acquisition Corp. Updates Beneficial Ownership Stakes
Hampton Financial Corp Raises Governance Concerns Over Icon Energy
HCA Healthcare Executive Reports Multiple Stock Transactions
LENZ Therapeutics updates beneficial ownership in SEC filing









